Dr. Dollin is a vitreoretinal surgeon and assistant professor at the University of Ottawa Eye Institute. He received his Honours Bachelor of Science with high distinction and Doctor of Medicine degrees from the University of Toronto. He completed his residency training in Ophthalmology at the University of Ottawa, where he was appointed Co-Chief Resident and awarded the Department of Ophthalmology Resident Teaching Award. He went on to complete a Retina fellowship at Wills Eye Hospital in Philadelphia, where he was twice awarded the P. Robb McDonald Award for best fellow research paper.

Dr. Dollin currently serves as the Eye Institute’s principal investigator on several major multicenter retina clinical trials and has presented his own research at large national and international academic meetings. He has co-authored scientific papers, book chapters, and non-peer reviewed articles. He serves as a reviewer for the journal Retina, the Journal of VitreoRetinal Diseases, and the Canadian Journal of Ophthalmology. He is also actively involved in teaching medical students, residents, and fellows at the University of Ottawa, and was awarded the Department of Ophthalmology Teacher of the Year Award in 2018.

Financial disclosure: Dr. Dollin has/had a relationship with a for-profit and/or not-for-profit organization:

1. Alcon

2. Bayer

3. Novartis